Cefepime Neurotoxicity: Underrecognized Risk or Overblown Concern?

Cefepime Neurotoxicity Underrecognized Risk or Overblown Concern   Abstract Cefepime is a fourth generation cephalosporin antibiotic that is widely utilized in clinical practice for the treatment of severe and life threatening bacterial infections, including hospital acquired pneumonia, febrile neutropenia, complicated urinary tract infections, and infections caused by

Epigenetics and Brain Plasticity: Can We Rewrite the Neurological Code?

Epigenetics and Brain Plasticity: Can We Rewrite the Neurological Code?   Introduction More than half of children are estimated to experience at least one form of early-life stress, contributing to 30–40% of all mood, drug, and psychiatric disorders. Neural plasticity, a remarkable characteristic of

Hidden Crisis: Why Sarcopenia Treatment Matters More Than You Think in 2025

Hidden Crisis: Why Sarcopenia Treatment Matters More Than You Think in 2025   Introduction Sarcopenia treatment represents a critical healthcare priority as the prevalence of this age-related muscle wasting condition reaches alarming levels. The economic burden of sarcopenia in the United States was approximately

Long COVID and the Brain: Decoding Post-Viral Neuroinflammation

Long COVID and the Brain: Decoding Post-Viral Neuroinflammation   Abstract Long COVID has emerged as a significant and evolving global health challenge, affecting millions of individuals following acute infection with SARS-CoV-2. While respiratory and systemic symptoms were initially the primary focus of clinical attention, it has

The Role of the Gut Microbiome in Neurological Disorders

The Role of the Gut Microbiome in Neurological Disorders   Abstract The gut microbiome has emerged as a central component in the evolving understanding of neurological health and disease. Advances in molecular biology, metagenomics, and neuroimmunology have revealed that the intestinal microbial ecosystem plays a significant role

Why Tau Antibody Trials Failed in Alzheimer’s: New Evidence Reveals Critical Gaps

Why Tau Antibody Trials Failed in Alzheimer’s New Evidence Reveals Critical Gaps Introduction Tau directed antibody therapies represent one of the most scientifically compelling yet clinically challenging areas in the treatment of Alzheimer’s disease. Alzheimer’s disease is a progressive neurodegenerative disorder whose prevalence doubles approximately

Radioligand Therapy Results: New Evidence in Treating Neuroendocrine Tumors

Radioligand Therapy Results New Evidence in Treating Neuroendocrine Tumors  Check out our extensive video library (see channel for our latest videos) Introduction Radioligand therapies have emerged as an important breakthrough in the management of neuroendocrine tumors, a group of heterogeneous neoplasms known

Neuroethics of Cognitive Enhancement: Where Should Neurologists Draw the Line?

Neuroethics of Cognitive Enhancement: Where Should Neurologists Draw the Line?  Check out our extensive video library (see channel for our latest videos) Abstract The rapid evolution of cognitive enhancement technologies presents neurologists and other healthcare professionals with increasingly complex ethical challenges. These challenges extend

Cefepime Neurotoxicity: Underrecognized Risk or Overblown Concern?